The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
One of the neuropathological hallmarks of Alzheimer's disease is the neurofibrillary tangle, which contains paired helical filaments (PHFs) composed of the microtubule-associated protein tau. Tau is hyperphosphorylated in PHFs, and phosphorylation of tau abolishes its ability to bind microtubules and promote microtubule assembly. Restoring the function of phosphorylated tau might prevent or reverse PHF formation in Alzheimer's disease. Phosphorylation on a serine or threonine that precedes proline (pS/T-P) alters the rate of prolyl isomerization and creates a binding site for the WW domain of the prolyl isomerase Pin1. Pin1 specifically isomerizes pS/T-P bonds and regulates the function of mitotic phosphoproteins. Here we show that Pin1 binds to only one pT-P motif in tau and copurifies with PHFs, resulting in depletion of soluble Pin1 in the brains of Alzheimer's disease patients. Pin1 can restore the ability of phosphorylated tau to bind microtubules and promote microtubule assembly in vitro. As depletion of Pin1 induces mitotic arrest and apoptotic cell death, sequestration of Pin1 into PHFs may contribute to neuronal death. These findings provide a new insight into the pathogenesis of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also growing evidence for the association between DNA damage and increased expression of cell-cycle markers in AD [34], [38].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [38]
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Self-citationMutation in the tau gene in familial multiple system tauopathy with presenile dementia
Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,112
Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17
Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003
A human peptidyl–prolyl isomerase essential for regulation of mitosis
Ping Lu, K., Hanes, S. D., & Hunter, T. (1996) · Nature · doi:10.1038/380544a0 · Cited by 904
Self-citationBramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J.-U., Xu, J., Kuang, J., Kirschner, M. W., Fischer, G., et al. (1997) · Science · doi:10.1126/science.278.5345.1957 · Cited by 770
Self-citationRole of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.
Alonso, A. C., Zaidi, T., Grundke-Iqbal, I., & Iqbal, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5562 · Cited by 738
Ranganathan, R., Lu, K. P., Hunter, T., & Noel, J. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80273-1 · Cited by 699
Self-citation
Cited by
Items 301–400 of 724
Thorpe, J. R., Mosaheb, S., Hashemzadeh-Bonehi, L., Cairns, N. J., Kay, J. E., Morley, S. J., & Rulten, S. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.008 · Cited by 44
Pin1 : A Therapeutic Target in Alzheimer Neurodegeneration
Hamdane, M., Smet‐Nocca, C., Sambo, A., Leroy, A., Wieruszeski, J., Delobel, P., Maurage, C., Ghestem, A., Wintjens, R. T., Bégard, S., et al. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:19:3:275 · Cited by 44
γ-Aminobutyric Acid Type A (GABAA) Receptor Activation Modulates Tau Phosphorylation
Nykänen, N.-P., Kysenius, K., Sakha, P., Tammela, P., & Huttunen, H. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309385 · Cited by 43
New insights into genetic and molecular mechanisms of brain degeneration in tauopathies
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00100-9 · Cited by 46
Nakatsu, Y., Iwashita, M., Sakoda, H., Ono, H., Nagata, K., Matsunaga, Y., Fukushima, T., Fujishiro, M., Kushiyama, A., Kamata, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.658559 · Cited by 47
Tau Aggregates and Tau Pathology
Hernández, F., & Avila, J. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14414 · Cited by 42
Pseudohyperphosphorylation Has Differential Effects on Polymerization and Function of Tau Isoforms
Combs, B., Voss, K., & Gamblin, T. C. (2011) · Biochemistry · doi:10.1021/bi2010569 · Cited by 41
A peptidyl–prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles
Sugata, H., Matsuo, K., Nakagawa, T., Takahashi, M., Mukai, H., Ono, Y., Maeda, K., Akiyama, H., & Kawamata, T. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.062 · Cited by 41
Proline Conformation in a Functional Tau Fragment
Ahuja, P., Cantrelle, F., Huvent, I., Hanoulle, X., Lopez, J. M., Smet‐Nocca, C., Wieruszeski, J., Landrieu, I., & Lippens, G. M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.11.023 · Cited by 40
The role of Pin1 in the development and treatment of cancer
Min, S., Zhou, X. Z., & Lu, K. P. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0821-x · Cited by 43
Self-citationBai, Q., & Burton, E. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.004 · Cited by 48
Non-catalytic participation of the Pin1 peptidyl-prolyl isomerase domain in target binding
Innes, B. T., Bailey, M. L., Brandl, C. J., Shilton, B. H., & Litchfield, D. W. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00018 · Cited by 51
Yan, S.-Z., Beeler, J. A., Chen, Y., Shelton, R. K., & Tang, W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010361200 · Cited by 44
Archaeal peptidyl prolyl cis-trans isomerases (PPIases)
Maruyama, T. (2000) · Frontiers in bioscience · doi:10.2741/a554 · Cited by 41
Sultana, R., Robinson, R. A. S., Di Domenico, F., Abdul, H. M., Clair, D. K. S., Markesbery, W. R., Cai, J., Pierce, W. M., & Butterfield, D. A. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.06.015 · Cited by 41
Wang, S., Jiang, Y. X., Liu, Y., Liu, Q., Sun, H., Mei, M., & Liao, X. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02731-8 · Cited by 41
Driver, J. A., Zhou, X. Z., & Lu, K. P. (2014) · PubMed · Cited by 39
Self-citationPtdIns5P and Pin1 in oxidative stress signaling
Keune, W., Jones, D. R., & Divecha, N. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.02.001 · Cited by 44
Gears-In-Motion: The Interplay of WW and PPIase Domains in Pin1
Lee, Y. M., & Liou, Y. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00469 · Cited by 48
Han, D., Qureshi, H. Y., Lu, Y., & Paudel, H. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901095200 · Cited by 40
Developmental mechanisms in the pathogenesis of neurodegenerative diseases
Mehler, M. F., & Gökhan, Ş. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00052-6 · Cited by 42
Combinatorial Tau Pseudophosphorylation
Kiris, E., Ventimiglia, D., Sargin, M. E., Gaylord, M. R., Altinok, A., Rose, K., Manjunath, B. S., Jordan, M. A., Wilson, L., & Feinstein, S. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219311 · Cited by 40
Lyons, A. J., Gandhi, N. S., & Mancera, R. L. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24544 · Cited by 38
Bending Tau into Shape: The Emerging Role of Peptidyl-Prolyl Isomerases in Tauopathies
Koren, J., Jinwal, U. K., Davey, Z. S., Kiray, J., Arulselvam, K., & Dickey, C. A. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8182-4 · Cited by 42
Nahreini, P., Hovland, A. R., Andreatta, C. P., Edwards‐Prasad, J., & Prasad, K. N. (2001) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007173329237 · Cited by 39
Yeast as a Model System to Study Tau Biology
Vos, A. D., Anandhakumar, J., den Brande, J. V., Verduyckt, M., Franssens, V., Winderickx, J., & Swinnen, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/428970 · Cited by 45
Recent Insights on Alzheimer’s Disease Originating from Yeast Models
Seynnaeve, D., Vecchio, M. D., Fruhmann, G., Verelst, J., Cools, M., Beckers, J., Mulvihill, D. P., Winderickx, J., & Franssens, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071947 · Cited by 42
Napoletano, F., Ferrari Bravo, G., Voto, I. A. P., Santin, A., Celora, L., Campaner, E., Dezi, C., Bertossi, A., Valentino, E., Santorsola, M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109694 · Cited by 36
Ang, B. K., Lim, C. Y., Koh, S. S., Sivakumar, N., Taib, S., Lim, K. B., Ahmed, S., Rajagopal, G., & Ong, S. H. (2007) · Journal of Molecular Signaling · doi:10.1186/1750-2187-2-1 · Cited by 41
Tau phosphorylation and assembly
Gómez‐Ramos, A., Smith, M. A., Perry, G. L., & Ávila, J. (2004) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2004-1489 · Cited by 40
Deleersnijder, A., Rompuy, A. V., Desender, L., Pottel, H., Buée, L., Debyser, Z., Baekelandt, V., & Gérard, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.182303 · Cited by 42
Nakamura, K., Zhou, X. Z., & Lu, K. P. (2013) · Prion · doi:10.4161/pri.22849 · Cited by 37
Self-citationYe, S., Wang, D., Xu, Y., Wang, C., Cao, L., Liu, Y., & Zhu, C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150486 · Cited by 38
Csokova, N. T., Škrabana, R., Liebig, H., Mederlyova, A., KONTSEK, P., & Novák, M. (2004) · Protein Expression and Purification · doi:10.1016/j.pep.2004.01.012 · Cited by 39
Involvement of the telomeric protein Pin2/TRF1 in the regulation of the mitotic spindle
Nakamura, M., Zhou, X. Z., Kishi, S., & Lu, K. P. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02363-3 · Cited by 45
Self-citationSolution Structure of the Single-domain Prolyl Cis/Trans Isomerase PIN1At from Arabidopsis thaliana
Landrieu, I., Wieruszeski, J., Wintjens, R. T., Inzé, D., & Lippens, G. M. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00429-1 · Cited by 37
Donison, N. S., Palik, J., Volkening, K., & Strong, M. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00842-z · Cited by 44
Determinants of eosinophil survival and apoptotic cell death
Shen, Z.-J., & Malter, J. S. (2015) · APOPTOSIS · doi:10.1007/s10495-014-1072-2 · Cited by 41
Jeong, S., Ryo, A., & Yamamoto, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.024 · Cited by 36
Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration
Sorrentino, G., Comel, A., Mantovani, F., & Sal, G. D. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.08.003 · Cited by 39
The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy
Rao, S. S., Portbury, S. D., Lago, L., Bush, A. I., & Adlard, P. A. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-209009 · Cited by 36
RETRACTED: The Iron Chelator Deferiprone Improves the Phenotype in a Mouse Model of Tauopathy1
Rao, S. S., Portbury, S. D., Lago, L., Bush, A. I., & Adlard, P. A. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200551 · Cited by 38
RetractedNegative Regulation of Peptidyl-Prolyl Isomerase Activity by Interdomain Contact in Human Pin1
Wang, X., Mahoney, B. J., Zhang, M., Zintsmaster, J. S., & Peng, J. W. (2015) · Structure · doi:10.1016/j.str.2015.08.019 · Cited by 38
The physiology and pathology of microtubule-associated protein tau
Wang, J., Gao, X., & Wang, Z.-H. (2014) · Essays in Biochemistry · doi:10.1042/bse0560111 · Cited by 49
Han, C. H., Lü, J., Wei, Q., Bondy, M. L., Brewster, A. M., Yu, T., Buchholz, T. A., Arun, B., & Wang, L. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0682-9 · Cited by 35
Rudrabhatla, P., Albers, W., & Pant, H. C. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4469-09.2009 · Cited by 39
Liu, Y., Liao, W.-C., Ger, L.-P., Chen, J.-C., Hsu, T., Lee, Y., Chang, H.-T., Chen, Y., Jan, Y., Lee, K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0518 · Cited by 35
Self-citationPin1 Deficiency Causes Endothelial Dysfunction and Hypertension
Chiasson, V. L., Munshi, N., Chatterjee, P., Young, K. J., & Mitchell, B. M. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.172338 · Cited by 35
Alzheimer's disease‐causing proline substitutions lead to presenilin 1 aggregation and malfunction
Ben‐Gedalya, T., Moll, L., Bejerano‐Sagie, M., Frère, S. G. A., Cabral, W. A., Friedmann‐Morvinski, D., Slutsky, I., Burstyn‐Cohen, T., Marini, J. C., & Cohen, E. (2015) · The EMBO Journal · doi:10.15252/embj.201592042 · Cited by 38
Alterations in Tau Metabolism in ALS and ALS-FTSD
Strong, M. J., Donison, N. S., & Volkening, K. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.598907 · Cited by 41
Nakatsu, Y., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Horike, N., Yoneda, M., Ohno, H., Tsuchiya, Y., Kamata, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.137836 · Cited by 38
Thorpe, J. R., Morley, S. J., & Rulten, S. L. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104900110 · Cited by 35
Gray, V. E., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr013 · Cited by 35
NMR Meets Tau: Insights into Its Function and Pathology
Lippens, G., Landrieu, I., Smet, C., Huvent, I., Gandhi, N., Gigant, B., Despres, C., Qi, H., & Lopez, J. (2016) · Biomolecules · doi:10.3390/biom6020028 · Cited by 34
Xu, L., Ren, Z., Chow, F. E., Tsai, R., Liu, T., Rizzolio, F., Boffo, S., Xu, Y., Huang, S., Lippa, C. F., et al. (2017) · Neural Plasticity · doi:10.1155/2017/3270725 · Cited by 33
Hinge-Shift Mechanism Modulates Allosteric Regulations in Human Pin1
Campitelli, P., Guo, J., Zhou, H., & Ozkan, S. B. (2018) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.7b11971 · Cited by 36
Lane, R. F., Shineman, D. W., Steele, J., Lee, L. H., & Fillit, H. M. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00007-6 · Cited by 38
Rudrabhatla, P., & Pant, H. C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1243 · Cited by 39
Role of Pin1 Protein in the Pathogenesis of Nonalcoholic Steatohepatitis in a Rodent Model
Nakatsu, Y., Otani, Y., Sakoda, H., Zhang, J., Guo, Y., Okubo, H., Kushiyama, A., Fujishiro, M., Kikuch, T., Fukushima, T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.397133 · Cited by 34
Lattanzio, F., Carboni, L., Carretta, D., Rimondini, R., Candeletti, S., & Romualdi, P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.017 · Cited by 38
Smet‐Nocca, C., Duckert, J., Wieruszeski, J., Landrieu, I., Buée, L., Lippens, G. M., & Deprez, B. P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0500119 · Cited by 34
Role of Pin2/TRF1 in telomere maintenance and cell cycle control
Zhou, X. Z., Perrem, K., & Lu, K. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10496 · Cited by 37
Self-citationCrosstalk of Prolyl Isomerases, Pin1/Ess1, and Cyclophilin A
Fujimori, F., Gunji, W., Kikuchi, J., Mogi, T., Ohashi, Y., Makino, T., Oyama, A., Okuhara, K., Uchida, T., & Murakami, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5925 · Cited by 37
Isolation and characterization of the Pin1/Ess1p homologue inSchizosaccharomyces pombe
Huang, H.-K., Forsburg, S. L., John, U. P., O’Connell, M. J., & Hunter, T. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.20.3779 · Cited by 35
Hwang, Y., Yang, C.-H., Lin, C.-H., Ch'ang, H.-J., Chang, V. H. S., & Yu, W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.010 · Cited by 33
Neighbored phosphorylation sites as PHF-tau specific markers in Alzheimer’s disease
Singer, D. L., Lehmann, J., Hanisch, K., Härtig, W., & Hoffmann, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.201 · Cited by 34
Ávila, J., Pallas‐Bazarra, N., Bolós, M., Sayas, C. L., & Hernández, F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1131269 · Cited by 38
NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease
Landrieu, I., Leroy, A., Smet‐Nocca, C., Huvent, I., Amniai, L., Hamdane, M., Sibille, N., Buée, L., Wieruszeski, J., & Lippens, G. M. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381006 · Cited by 38
Alzheimer Disease and Cancer: A National Inpatient Sample Analysis
Sherzai, A. Z., Parasram, M., Haider, J. M., & Sherzai, D. (2020) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000369 · Cited by 32
Smet‐Nocca, C., Launay, H. M. M., Wieruszeski, J., Lippens, G. M., & Landrieu, I. (2013) · Journal of Biomolecular NMR · doi:10.1007/s10858-013-9716-z · Cited by 32
van Tiel, C. M., Kurakula, K., Koenis, D. S., van der Wal, E., & de Vries, C. J. M. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.06.030 · Cited by 32
Rudrabhatla, P., Zheng, Y., Amin, N. D., Kesavapany, S., Albers, W., & Pant, H. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801633200 · Cited by 32
Lu, L. (2009) · Oncology Reports · doi:10.3892/or_00000329 · Cited by 37
Hamdane, M., & Buée, L. (2007) · Biotechnology Journal · doi:10.1002/biot.200700059 · Cited by 38
Animal Models of Neurological Disease
Shah, A., Garzón-Muvdi, T., Mahajan, R. K., Duenas, V. J., & Quiñones-Hinojosa, A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5819-8_3 · Cited by 32
Different tau epitopes define Aβ42-mediated tau insolubility
Pennanen, L., & Götz, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.168 · Cited by 36
Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration
Butterfield, D. A., & Boyd-Kimball, D. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)61007-5 · Cited by 31
Therapeutic Strategies for Restoring Tau Homeostasis
Young, Z. T., Mok, S. A., & Gestwicki, J. E. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024612 · Cited by 31
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology
Kalyaanamoorthy, S., Opare, S. K. A., Xu, X., Ganesan, A., & Rao, P. P. N. (2024) · Current Alzheimer Research · doi:10.2174/0115672050301407240408033046 · Cited by 32
Bosco, D. A., Eisenmesser, E. Z., Clarkson, M. W., Wolf‐Watz, M., Labeikovsky, W., Millet, Ó., & Kern, D. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.001 · Cited by 34
Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures
Rankin, C. A., Sun, Q., & Gamblin, T. C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.011 · Cited by 36
Qin, X., Wang, Y., & Paudel, H. K. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.018 · Cited by 40
Pin1 mediates Aβ 42 -induced dendritic spine loss
Stallings, N. R., O’Neal, M. A., Hu, J., Kavalali, E. T., Bezprozvanny, I., & Malter, J. S. (2018) · Science Signaling · doi:10.1126/scisignal.aap8734 · Cited by 29
Ariyannur, P. S., Xing, G., Barry, E. S., Benford, B., Grunberg, N. E., & Sharma, P. (2021) · Aging and Disease · doi:10.14336/ad.2020.1015 · Cited by 30
Distinct phosphorylation profiles of tau in brains of patients with different tauopathies
Samimi, N., Sharma, G., Kimura, T., Matsubara, T., Huo, A., Chiba, K., Saito, Y., Murayama, S., Akatsu, H., Hashizume, Y., et al. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.08.011 · Cited by 29
Unraveling the Role of Peptidyl-Prolyl Isomerases in Neurodegeneration
Gérard, M., Deleersnijder, A., Demeulemeester, J., Debyser, Z., & Baekelandt, V. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8184-2 · Cited by 36
Tau binds both subunits of calcineurin, and binding is impaired by calmodulin
Yu, D., Li, T., Song, G., Lin, W., Zhang, L.-Q., Bai, W., Gong, H., Yin, Y., & Wei, Q. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.06.015 · Cited by 32
Kinetic Isotope Effects Support the Twisted Amide Mechanism of Pin1 Peptidyl-Prolyl Isomerase
Mercedes-Camacho, A. Y., Mullins, A. B., Mason, M. D., Xu, G. G., Mahoney, B. J., Wang, X., Peng, J. W., & Etzkorn, F. A. (2013) · Biochemistry · doi:10.1021/bi400700b · Cited by 29
Kobeissy, F. H., Guingab-Cagmat, J. D., Zhang, Z., Moghieb, A. M., Glushakova, O. Y., Mondello, S., Boutté, A. M., Anagli, J. Y., Rubenstein, R., Bahmad, H. F., et al. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00198 · Cited by 29
P24, a glycogen synthase kinase 3 (GSK 3) inhibitor
Martı́n, C. P., Vázquez, J., Ávila, J., & Moreno, F. J. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00092-8 · Cited by 33
Velazquez, H. A., & Hamelberg, D. (2011) · Biochemistry · doi:10.1021/bi2009954 · Cited by 28
Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis
Li, J., Mo, C., Guo, Y., Zhang, B., Feng, X., Si, Q., Wu, X., Zhao, Z., Gong, L., He, D., et al. (2021) · Theranostics · doi:10.7150/thno.45889 · Cited by 34
A Novel Role for hGas7b in Microtubular Maintenance
Akiyama, H., Gotoh, A., Shin, R., Koga, T., Ohashi, T., Sakamoto, W., Harada, A., Arai, H., Sawa, A., Uchida, C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035998 · Cited by 28
Kamah, A., Cantrelle, F., Huvent, I., Giustiniani, J., Guillemeau, K., Byrne, C., Jacquot, Y., Landrieu, I., Baulieu, E. E., Smet‐Nocca, C., et al. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.02.015 · Cited by 29
Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Nakatsu, Y., Matsunaga, Y., Ueda, K., Yamamotoya, T., Inoue, Y., Inoue, M.-K., Mizuno, Y., Kushiyama, A., Ono, H., Fujishiro, M., et al. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181105120911 · Cited by 28
KeePin’ the p53 Family in Good Shape
Mantovani, F., Gostissa, M., Collavin, L., & Sal, G. D. (2004) · Cell Cycle · doi:10.4161/cc.3.7.999 · Cited by 32
Caudle, W. M., Pan, S., Shi, M. Y., Quinn, T. J., Hoekstra, J. G., Beyer, R. P., Montine, T. J., & Zhang, J. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800043 · Cited by 27
Weinger, J. G., Davies, P., Acker, C. M., Brosnan, C. F., Tsiperson, V., Bayewitz, A., & Shafit-Zagardo, B. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182540d2e · Cited by 27
Self-citationChang, Y.-H., Shaw, C., Jian, S.-H., Hsieh, K.-H., Chiou, Y., & Lu, P. (2009) · Kidney International · doi:10.1038/ki.2009.258 · Cited by 27
Self-citationBhaduri, A., Misra, R., Maji, A., Bhetariya, P. J., Mishra, S., Arora, G., Singh, L. K., Dhasmana, N., Dubey, N., Virdi, J. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088090 · Cited by 28
Metadata
- Authors
- Lu, P.-J., Wulf, G., Zhou, X. Z., Davies, P., & Lu, K. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Lu, Kun Ping
- Venue
- Nature
- Published
- 1999-06
- Volume
- 399
- Issue
- 6738
- Pages
- 784-788
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1541944730
- Cited by
- 721
- References
- 30
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 22 · 2023: 26 · 2022: 20 · 2021: 18 · 2020: 20 · 2019: 23 · 2018: 34 · 2017: 25 · 2016: 28 · 2015: 36 · 2014: 31 · 2013: 37 · 2012: 37
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Pin1, peptidyl-prolyl isomerase, tau phosphorylation, Alzheimer's disease, neurofibrillary tangles, paired helical filaments, microtubule binding, microtubule assembly, WW domain, mitotic arrest, neuronal apoptosis, protein depletion
- MeSH terms
- NIMA-Interacting Peptidylprolyl Isomerase, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Glutathione Transferase, Humans, Microtubules, Mitosis, Molecular Sequence Data, Phosphorylation, Protein Binding, Recombinant Fusion Proteins, Xenopus, tau Proteins, Apoptosis, Peptidylprolyl Isomerase, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.